BioengineeringBioconjugate ChemistryPeer-reviewed
Targeting both GD2 and B7-H3 using bispecific antibody improves tumor selectivity for GD2-positive tumors
Zachary T. Rosenkrans, Amy K. Erbe, Nathan B. Clemons…·Reinier T. Hernandez
This paper develops a bispecific antibody targeting GD2 and B7-H3 to improve tumor selectivity and reduce toxicity in GD2-positive tumors.
8 citations